Core Insights - Diginex Limited reported a transformative fiscal year ending March 31, 2025, highlighted by a 57% increase in revenues and the successful completion of its IPO in January 2025 [4][5][17] - The company signed strategic agreements with professional firms to enhance future revenues and client acquisition, while also introducing AI-powered compliance solutions [4][5] - Diginex is pursuing a dual listing on the Abu Dhabi Securities Exchange to increase exposure to investors and support sustainable finance initiatives in the GCC region [4][5] Financial Performance - Total revenue for the fiscal year increased by 57% to $2.0 million, driven primarily by software subscriptions and license fees [5][8] - The net loss for the fiscal year was $5.2 million, an increase of $0.3 million compared to the previous year's loss of $4.9 million [5][24] - General and administrative expenses rose to $10.3 million, primarily due to IPO-related professional fees and share-based payments [13][24] Revenue Breakdown - Revenue from subscription and license fees increased significantly to $1.3 million from $0.4 million, while advisory fees rose modestly to $0.3 million [7][9] - Customization fees decreased to $0.4 million from $0.7 million, reflecting a strategic shift towards core product development [10][11] Balance Sheet Highlights - As of March 31, 2025, Diginex reported net assets of $4.6 million, a significant improvement from net liabilities of $23.0 million the previous year [15][23] - The company's cash position improved to $3.1 million from $0.1 million at the end of the prior fiscal year [15][23] Strategic Initiatives - Diginex signed memoranda of understanding to acquire Resulticks Group Companies and Matter DK ApS, aimed at enhancing its technology and data capabilities [5][6] - The planned acquisitions are expected to expand Diginex's AI-driven data management and sustainability analytics capabilities [6][17]

MILFORD, Mass., July 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2025 financial results conference call on Monday, August 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least September 2nd, 2025, at midnight Eastern Time.About Waters CorporationWaters Corporation (NYSE:WAT) is a global leader in analytical instruments, s ...

MONTREAL, July 11, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to announce it has closed yesterday the Non-Brokered Private placement financing first announced on May 29, 2025. In addition to the 3,158,000 units announced on June 19, 2025, the company announces the closing of additional 1,886,331 units at a price of $ 0.18 per unit for a gros ...

Emerson Electric (EMR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this maker of process controls systems, valves and analytical instruments have returned +11% over the past month versus the Zacks S&P 500 composite's +4.1% change. The Zacks Manufacturing - Electronics industry, to which Emerson Electric belongs, has gained 10% over this period. Now th ...

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call & Webcast Thursday, August 7 @ 4:30 p.m. ET Domestic: 1 833-470-1428International: 1 404-975-4839Access Code: 899803 Webcast: Participants can use the ...

In an era when artificial intelligence (AI) and quantum computing stocks are generating more hype than ever, it is easy to overlook reliable compounders with wide moats. One of my personal favorites is North America's largest trash and recycling juggernaut, Waste Management (WM -0.10%).Since the turn of the millennium, Waste Management has been a 23-bagger -- quadrupling the total returns of the S&P 500 (^GSPC 0.27%). Better yet, for passive income seekers, the company increased its dividend payments for 21 ...

Financial Results Announcement - Midland States Bancorp, Inc. will issue its second quarter 2025 financial results after market close on July 24, 2025 [1] - An investor presentation will accompany the financial results and will be available on the company's investor relations website [1] Company Overview - Midland States Bancorp, Inc. is a community-based financial holding company headquartered in Effingham, Illinois [2] - The company is the sole shareholder of Midland States Bank and had total assets of approximately $7.28 billion as of March 31, 2025 [2] - The Wealth Management Group of the company had assets under administration of approximately $4.10 billion [2] - The company offers a full range of commercial and consumer banking products and services, including business equipment financing, merchant credit card services, trust and investment management, insurance, and financial planning services [2]

Core Points - Crinetics Pharmaceuticals granted non-qualified stock option awards for 102,350 shares and restricted stock unit (RSU) awards for 77,875 shares to 46 new non-executive employees as part of the 2021 Employment Inducement Incentive Award Plan [1][2] - The stock options have an exercise price of $31.99 per share, equal to the closing price on July 10, 2025, and will vest over four years [2] - Crinetics Pharmaceuticals is focused on developing novel therapeutics for endocrine diseases and related tumors, with lead candidate paltusotine in clinical development for acromegaly and carcinoid syndrome [3] Summary by Category Stock Options and RSUs - The stock options and RSUs were granted as inducements for new employees under the 2021 Inducement Plan, in compliance with Nasdaq Listing Rule 5635(c)(4) [1][2] - Stock options will vest 25% after one year, with the remainder vesting in 36 equal monthly installments, contingent on continued employment [2] - RSUs will vest in equal annual installments over four years, also dependent on continued employment [2] Company Overview - Crinetics Pharmaceuticals is a clinical stage pharmaceutical company specializing in endocrine diseases and tumors [3] - The company’s lead candidate, paltusotine, is the first investigational oral selective somatostatin receptor type 2 nonpeptide agonist [3] - Other drug candidates in development include treatments for congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome, with a focus on orally delivered small molecules [3]

Core Viewpoint - 10x Genomics, Inc. will report its financial results for Q2 2025 on August 7, 2025, and will host a conference call to discuss these results and future outlook [1]. Group 1: Financial Reporting - The financial results for the second quarter ended June 30, 2025, will be announced after market close on August 7, 2025 [1]. - A public conference call and live webcast for analysts and investors will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [1]. Group 2: Company Overview - 10x Genomics is a life science technology company focused on products that enhance the understanding of biology and improve human health [3]. - The company offers integrated research solutions, including instruments, consumables, and software for single cell and spatial biology, aiding researchers in comprehending complex biological systems [3]. - Its products contribute to advancements in various fields such as oncology, immunology, and neuroscience, leading to significant discoveries in health and disease [3]. Group 3: Disclosure Practices - 10x Genomics utilizes various channels, including SEC filings, press releases, and social media, to disclose material non-public information and comply with disclosure obligations [4].

Core Insights - MKS Inc. has been recognized as one of America's Best Mid-Sized Companies for 2025 by Time and Statista, Inc. [1][2] - The recognition is attributed to employee satisfaction, revenue growth, and sustainability transparency, evaluated through over 15 criteria [2] Company Overview - MKS Inc. is a global provider of enabling technologies that transform various industries, particularly in semiconductor manufacturing, electronics, and specialty industrial applications [3] - The company focuses on delivering foundational technology solutions, including instruments, subsystems, systems, process control solutions, and specialty chemicals technology [3] - MKS's solutions address challenges in miniaturization and complexity in advanced device manufacturing, enhancing power, speed, feature enhancement, and connectivity [3]